- Home
- LCID vs RNA Comparison
LCID vs RNA Comparison
Compare LCID & RNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | LCID | RNA |
|---|---|---|
| Founded | 2007 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Auto Manufacturing | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.1B | 4.0B |
| IPO Year | N/A | 2020 |
Fundamental Metrics
Financial Performance| Metric | LCID | RNA |
|---|---|---|
| Price | $11.87 | $71.78 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 8 | 20 |
| Target Price | $24.00 | ★ $69.26 |
| AVG Volume (30 Days) | ★ 8.1M | 2.4M |
| Earning Date | 11-05-2025 | 11-10-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $1,065,533,000.00 | $20,868,000.00 |
| Revenue This Year | $64.89 | $64.11 |
| Revenue Next Year | $82.13 | $37.25 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | 45.86 | ★ 106.27 |
| 52 Week Low | $11.46 | $21.51 |
| 52 Week High | $36.40 | $71.88 |
Technical Indicators
Market Signals| Indicator | LCID | RNA |
|---|---|---|
| Relative Strength Index (RSI) | 34.46 | 74.68 |
| Support Level | $12.14 | $71.18 |
| Resistance Level | $13.21 | $71.79 |
| Average True Range (ATR) | 0.71 | 0.34 |
| MACD | 0.10 | -0.58 |
| Stochastic Oscillator | 0.41 | 85.71 |
Price Performance
Historical ComparisonAbout LCID Lucid Group Inc.
Lucid Group Inc is a technology and automotive company. It develops the next generation of electric vehicle (EV) technologies. It offers its own geographically distributed retail and service locations and through direct-to-consumer online and retail sales. It also boasts a product roadmap of future vehicle programs and technologies. It focuses on in-house hardware and software innovation, vertical integration, and a clean-sheet approach to engineering and design led to the development of the Lucid Air. The Lucid Air is a luxury sedan that redefines both the luxury car segment and the EV space. Its geographic segments include North America, the Middle East, and Other International.
About RNA Avidity Biosciences Inc.
Avidity Biosciences Inc is a biopharmaceutical company committed to delivering a new class of RNA therapeutics called Antibody Oligonucleotide Conjugates, or AOCs. Company's pipeline currently has three programs in potentially registrational clinical trials: DM1, FSHD, and DMD. The segments includes following: Del-zota for DMD44, Del-desiran for DM1, Del-brax for FSHD.